Nutrien (NTR) Q4 2025 earnings review
Potash Surges, Nitrogen Shrinks, Portfolio Simplifies
Nutrien delivered a strong finish to FY25, with Q4 Net Earnings jumping 392% YoY to $580M, though heavily aided by a $301M gain from the Profertil divestiture. Adjusted EBITDA rose 21% to $1.28B, driven primarily by Potash (EBITDA +53%) and Nitrogen pricing. However, the portfolio is shrinking: the permanent shutdowns of Trinidad and New Madrid Nitrogen facilities will slash FY26 Nitrogen sales volumes by ~13%. While Retail faltered in Q4 (-9% EBITDA) due to weather, the FY26 outlook relies on Potash stability and Retail efficiency to offset the structural loss of Nitrogen volume.
🐂 Bull Case
Potash Adjusted EBITDA surged 53% in Q4, driven by higher net selling prices ($262/t vs $194/t) and record annual sales volumes (14.25M tonnes). Global demand remains robust with shipment forecasts raised for 2026.
The simplification strategy is generating cash. The Profertil sale netted ~$600M, contributing to ~$900M in total divestiture proceeds. This strengthens the balance sheet and fuels the $551M in share repurchases executed in 2025.
🐻 Bear Case
The shutdowns of Trinidad (1.4M tonnes) and New Madrid (0.2M tonnes) remove ~15% of FY25's Nitrogen sales volume capacity. FY26 guidance calls for 9.2-9.7M tonnes, a sharp decline from the 10.89M tonnes sold in FY25.
Retail Adjusted EBITDA fell 9% in Q4 to $311M due to a weather-shortened fall application window. This highlights the segment's continued volatility despite cost-cutting measures.
⚖️ Verdict: 🟢
Bullish. While the structural reduction in Nitrogen volumes is a headwind, the underlying profitability of the remaining assets is improving (Ammonia operating rate +4%). The massive 53% jump in Potash profitability and disciplined cost management (beating targets) suggest high-quality earnings growth ahead.
Key Themes
Potash Margin Expansion
Potash was the standout performer in Q4. Adjusted EBITDA grew 53% YoY to $445M. This wasn't just volume; it was margin expansion driven by a 35% increase in realized prices ($262/tonne vs $194/tonne). Automation is also paying off, with 49% of ore tonnes mined using automation in 2025, cementing a low-cost advantage.
Structural Nitrogen Decline
Nutrien is shrinking its Nitrogen footprint to improve quality. The shutdown of Trinidad (Oct 2025) and New Madrid (Year-end 2025) removes 1.6 million tonnes of sales volume. FY26 guidance of 9.2-9.7 million tonnes represents a ~13% decline from FY25 actuals. While these were 'marginal free cash flow' assets, the scale reduction is significant.
Strategic Portfolio Simplification
Management is aggressively culling the portfolio. The sale of the 50% stake in Profertil generated a $301M gain in Q4 and ~$600M in proceeds. Total divestitures yielded ~$900M gross proceeds since Q4 2024. This simplifies operations and provides immediate cash for shareholder returns (buybacks) and debt reduction.
Retail Seasonality & Weather Impact
Q4 Retail sales fell 1% and Adjusted EBITDA fell 9% to $311M. A 'weather-shortened fall application window' in the US hurt Crop Nutrient sales volumes (-13% YoY for North America). While FY25 Retail EBITDA grew 2% overall due to cost cuts, the Q4 miss reinforces the segment's vulnerability to weather patterns.
Global Agriculture Fundamentals
The macro backdrop remains supportive but mixed. Global grain stocks-to-use ratios are near historical averages. US crop acres for 2026 are expected to be consistent with 2025 (Corn 94-96M acres). However, weaker affordability in Brazil is driving 'just-in-time' purchasing and a shift to lower-analysis products.
Other KPIs
Operating Cash Flow ($6.0B, calculated from EBITDA/Capex proxies in text) less Capital Expenditures ($2.0B). Strong generation supported $1.6B in dividends and $551M in share repurchases (2% of float). The company continues to prioritize returning cash to shareholders.
Accelerating. Up 165% from just $20M in 24Q4. While a small segment, margins expanded significantly due to higher net selling prices ($733/t vs $671/t) and improved reliability, despite higher sulfur input costs.
Improved from -$160M in 24Q4. The Purchase for Resale business was moved to this segment (restated history). The improvement reflects lower functional costs and general administrative discipline.
Guidance
Accelerating. Midpoint implies ~6% growth vs FY25 ($1.74B). Drivers include high-single digit growth in proprietary product margins and continued cost reductions. Assumes mid-single digit volume growth in North America.
Stable/Accelerating. Midpoint (14.45M) is slightly above the FY25 record of 14.25M tonnes. Reflects expectations of tight global supply and demand growth of ~2M tonnes globally (to 74-77M tonnes).
Reversing. Down sharply (~13%) from 10.89M tonnes in FY25. This is entirely due to the divestiture/closure of Trinidad and New Madrid assets. However, remaining assets are expected to run at high utilization.
Stable. Flat vs 2025 actuals ($2.0B). Management is maintaining strict capital discipline, prioritizing sustaining capital and automation projects over major greenfield expansion.
Key Questions
Phosphate Strategic Review
The release mentions the review of strategic alternatives for Phosphate intends to 'solidify the optimal path in 2026'. With Phosphate margins improving ($53M vs $20M in Q4), does this increase the likelihood of retention vs divestiture?
Nitrogen Fixed Cost Absorption
With Nitrogen volumes guiding down ~13% due to asset closures, how should we think about fixed cost absorption and unit margins for the remaining North American assets in FY26?
Retail Brazil Recovery
Retail EBITDA improved due to the 'Brazil margin improvement plan'. Can you quantify how much of the FY26 Retail growth guidance ($1.75-$1.95B) relies on further Brazil recovery vs North American volume growth?